Cecile Bonnafous

Person

Marseille, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 12,084,498
- Issue date Sep 10, 2024
- Innate Pharma
- Cecile Bonnafous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 11,999,784
- Issue date Jun 4, 2024
- Innate Pharma
- Cécile Bonnafous
- G01 - MEASURING TESTING
Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 11,078,275
- Issue date Aug 3, 2021
- Innate Pharma
- Cecile Bonnafous
- G01 - MEASURING TESTING
Information Patent Grant
Methods for detecting tissue infiltrating NK cells
- Patent number 10,736,963
- Issue date Aug 11, 2020
- Innate Pharma
- Nadia Anceriz
- G01 - MEASURING TESTING
Information Patent Grant
Mica binding agents
- Patent number 10,577,416
- Issue date Mar 3, 2020
- Innate Pharma, S.A.
- Mathieu Blery
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of anti-KIR and anti-CS1 antibodies to treat multiple m...
- Patent number 10,494,433
- Issue date Dec 3, 2019
- Bristol-Myers Squibb Company
- Pascale Andre
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of peripheral T cell lymphoma
- Patent number 10,344,087
- Issue date Jul 9, 2019
- Innate Pharma
- Cécile Bonnafous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound that specifically binds to KIR3DL2 for use in the treatmen...
- Patent number 10,174,112
- Issue date Jan 8, 2019
- Innate Pharma
- Cecile Bonnafous
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TLR3 binding agents
- Patent number 9,944,712
- Issue date Apr 17, 2018
- Innate Pharma
- Cécile Bonnafous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20240425586
- Publication date Dec 26, 2024
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
IMMUNOHISTOCHEMISTRY METHODS AND KIR3DL2-SPECIFIC REAGENTS
- Publication number 20240117042
- Publication date Apr 11, 2024
- Innate Pharma
- BENJAMIN ROSSI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20210363248
- Publication date Nov 25, 2021
- Innate Pharma
- CECILE BONNAFOUS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MICA BINDING AGENTS
- Publication number 20200299380
- Publication date Sep 24, 2020
- Innate Pharma
- Mathieu Blery
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20190315857
- Publication date Oct 17, 2019
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20190127463
- Publication date May 2, 2019
- Innate Pharma
- CECILE BONNAFOUS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR DETECTING TISSUE INFILTRATING NK CELLS
- Publication number 20180369373
- Publication date Dec 27, 2018
- Innate Pharma
- NADIA ANCERIZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...
- Publication number 20170298132
- Publication date Oct 19, 2017
- Innate Pharma
- CECILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE M...
- Publication number 20160257750
- Publication date Sep 8, 2016
- Bristol-Myers Squibb Company
- Pascale ANDRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATM...
- Publication number 20160002345
- Publication date Jan 7, 2016
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
- Publication number 20150376274
- Publication date Dec 31, 2015
- Innate Pharma
- CÉCILE BONNAFOUS
- G01 - MEASURING TESTING
Information Patent Application
MICA BINDING AGENTS
- Publication number 20150191542
- Publication date Jul 9, 2015
- Innate Pharma, S.A.
- Mathieu Blery
- G01 - MEASURING TESTING
Information Patent Application
TLR3 BINDING AGENTS
- Publication number 20150140000
- Publication date May 21, 2015
- Innate Pharma
- Cécile Bonnafous
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TLR3 BINDING AGENTS
- Publication number 20140065154
- Publication date Mar 6, 2014
- Innate Pharma
- Laurent Gauthier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Using Phosphoantigen for the Treatment of Cancer
- Publication number 20100029674
- Publication date Feb 4, 2010
- Innate Pharma, S.A.
- Jérôme Tiollier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Cecile Bonnafous

Person

Patents Grantslast 30 patents

Compound that specifically binds to KIR3DL2 for use in the treatmen...

Treatment of peripheral T cell lymphoma

Compound that specifically binds to KIR3DL2 for use in the treatmen...

Methods for detecting tissue infiltrating NK cells

Mica binding agents

Combination of anti-KIR and anti-CS1 antibodies to treat multiple m...

Treatment of peripheral T cell lymphoma

Compound that specifically binds to KIR3DL2 for use in the treatmen...

TLR3 binding agents

Patents Applicationslast 30 patents

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

IMMUNOHISTOCHEMISTRY METHODS AND KIR3DL2-SPECIFIC REAGENTS

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

MICA BINDING AGENTS

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

METHODS FOR DETECTING TISSUE INFILTRATING NK CELLS

COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMEN...

COMBINATION OF ANTI-KIR AND ANTI-CS1 ANTIBODIES TO TREAT MULTIPLE M...

A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATM...

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

MICA BINDING AGENTS

TLR3 BINDING AGENTS

TLR3 BINDING AGENTS

Methods of Using Phosphoantigen for the Treatment of Cancer